Healthcare provider profile · identity verified

Alison Mitchell, MD

Family Practice · PORTLAND, OR · NPI 1003919887

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	316	91
Levothyroxine Sodium	Levothyroxine Sodium	192	47
Amlodipine Besylate	Amlodipine Besylate	150	48
Losartan Potassium	Losartan Potassium	144	45
Lisinopril	Lisinopril	112	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	25
Escitalopram Oxalate	Escitalopram Oxalate	99	24
Omeprazole	Omeprazole	87	27
Metoprolol Succinate	Metoprolol Succinate	86	27
Gabapentin	Gabapentin	75	26
Metformin Hcl	Metformin Hcl	73	24
Trazodone Hcl	Trazodone Hcl	68	21
Simvastatin	Simvastatin	64	23
Rosuvastatin Calcium	Rosuvastatin Calcium	59	19
Metformin Hcl Er	Metformin Hcl	58	21
Hydrochlorothiazide	Hydrochlorothiazide	53	18
Sertraline Hcl	Sertraline Hcl	53	17
Alendronate Sodium	Alendronate Sodium	49	14
Pantoprazole Sodium	Pantoprazole Sodium	48	11
Citalopram Hbr	Citalopram Hydrobromide	46	14
Furosemide	Furosemide	46	13
Albuterol Sulfate Hfa	Albuterol Sulfate	45	20
Eliquis	Apixaban	45	13
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	11
Tramadol Hcl	Tramadol Hcl	36	suppressed
Potassium Chloride	Potassium Chloride	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	23
Famotidine	Famotidine	33	suppressed
Lorazepam	Lorazepam	33	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Ozempic	Semaglutide	32	suppressed
Atenolol	Atenolol	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	suppressed
Carvedilol	Carvedilol	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Estradiol	Estradiol	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Meloxicam	Meloxicam	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Temazepam	Temazepam	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Prednisone	Prednisone	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Baclofen	Baclofen	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error